COST vs MDLZ: Which is Better to Buy in 2026?

Side-by-side fundamental comparison based on AI analysis of SEC filings

AI Verdict

COST has stronger fundamentals based on our AI analysis.

COST
COSTCO WHOLESALE CORP /NEW
BUY
81%
Confidence
VS
MDLZ
Mondelez International, Inc.
HOLD
74%
Confidence

COST vs MDLZ Fundamental Comparison

Metric COST MDLZ
Revenue $136.9B $38.5B
Net Income $4.0B $2.5B
Net Margin 2.9% 6.4%
ROE 12.6% 9.5%
ROA 4.8% 3.4%
Current Ratio 1.06x 0.59x
Debt/Equity 0.18x 0.67x
EPS $9.08 $1.89

Green = Better metric | Red = Weaker metric

View Full COST Analysis →
View Full MDLZ Analysis →
Browse Sectors: Technology Healthcare Finance Energy Consumer Industrial
Stock Lists: Strong Buy Undervalued Growth Dividend

You Might Also Compare

COST vs AAPL MDLZ vs MSFT COST vs GOOGL MDLZ vs AMZN

COST vs MDLZ: Frequently Asked Questions

Is COST or MDLZ a better buy in 2026?

Based on dual AI fundamental analysis (Claude and ChatGPT), COST has stronger fundamentals. COST is rated BUY (81% confidence) while MDLZ is rated HOLD (74% confidence). This is not investment advice.

How does COST compare to MDLZ fundamentally?

COSTCO WHOLESALE CORP /NEW has ROE of 12.6% vs Mondelez International, Inc.'s 9.5%. Net margins are 2.9% vs 6.4% respectively.

Which stock pays higher dividends, COST or MDLZ?

COST has a dividend yield of N/A or no dividend while MDLZ has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.

Should I invest in COST or MDLZ for long term?

For long-term investing, consider that COST has BUY rating with 81% confidence, while MDLZ has HOLD rating with 74% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.

What do the AI models say about COST vs MDLZ?

Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For COST vs MDLZ, the AI consensus favors COST based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.